APUS reverse split history: Apimeds Pharmaceuticals US, Inc.

Listed on NYSE American. Split dates, ratios and the filings behind them.

Split history

1 reverse split in the last 5 years2-year cumulative ratio not stated: a split in the window has only one source

Effective date	Direction	Ratio	Status
Jul 24, 2026	Reverse	1 to 10	Took effect
Mar 26, 2026	Reverse	1 to 10	Took effect, unconfirmed (one source)

Exchange listing context

general deficiencyNYSE Americanfiled Apr 22, 2026
Not marked resolved in the index.
SEC filing 000121390026046671

Exchange deficiency notices Signal8 detected in 8-K Item 3.01 filings. No notice listed means none was found in that index, not that the company is in compliance.

Approval timeline

Locked

3 tracked episodes on record. Every filing and step from proposal to effective date.

Included with SplitScanner ($9.99 a month) and Signal8 Pro.

Unlock with SplitScanner

How it traded after each split

Locked

1 executed reverse split on record. The move over the 30 days after each one, on one split basis.

Included with SplitScanner ($9.99 a month) and Signal8 Pro.

Unlock with SplitScanner

Float before and after

Locked

24 float samples on record. Float around each split, from the daily float record.

Included with SplitScanner ($9.99 a month) and Signal8 Pro.

Unlock with SplitScanner

AI summaries of the filings

Locked

2 analysed filing or releases on record. Plain-English readings of each filing and press release about the split, from the Signal8 analysis.

Included with SplitScanner ($9.99 a month) and Signal8 Pro.

Unlock with SplitScanner

Split dates and ratios come from the market split calendar and are cross-checked against a second source; a row only one source evidences is marked unconfirmed. Funds, ETFs and other non-equity securities are excluded. The index is keyed by ticker symbol, so a company that changed symbol between splits appears under each symbol.